Last reviewed · How we verify

NCT06078527

Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort

Not yet recruiting NA Last updated 23 July 2025
What this trial tests

NA trial testing Cheung-Bearelly Aesthesiometer in Presbylarynx in 40 participants. Not yet recruiting.

Timeline
1 October 2025
Primary endpoint
31 January 2028
31 January 2028

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment40
Start date1 October 2025
Primary completion31 January 2028
Estimated completion31 January 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

Adults 18 to 85, any sex, with Presbylarynx or Aspiration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A previous study completed in 2022 (NCT05158179) was conducted using cohorts of healthy controls, and adults with general laryngopharyngeal disorders. This study will expand on the previous research to include a separate cohort of adults being seen in clinic for an existing laryngopharyngeal disorder resulting from previous radiation or other cancer treatments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Presbylarynx

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06078527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing